Results 21 to 30 of about 1,078,518 (304)
Background The objective was to evaluate cost-utility of bariatric surgery in Germany for a lifetime and 10-year horizon from a health care payer perspective.
Oleg Borisenko +2 more
doaj +1 more source
Background Lungsco01 is the first study assessing the real benefits and the medico-economic impact of video-thoracoscopy versus open thoracotomy for non-small cell lung cancer in the French context.
Anne-Laure Soilly +13 more
doaj +1 more source
Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as ...
Hugo C. Turner +9 more
doaj +1 more source
Cost-utility analysis of an implant treatment in dentistry [PDF]
Abstract Background When dealing with the replacement of one missing tooth, the patient has the option of choosing between different types of treatment interventions. Several important factors play a role in his decision-making process, including his limited financial means and his efforts to solve the problem of missing
Johana Losenická +2 more
openaire +3 more sources
Background Economic viability of treatments for primary open-angle glaucoma (POAG) should be assessed objectively to prioritise health care interventions.
Bozzani Fiammetta Maria +3 more
doaj +1 more source
Decision Rules in Cost-Utility Analysis of Health Technologies
This review identified 4 distinct decision rules used in the cost-utility analysis of health technologies: threshold incremental cost-effectiveness ratio (ICER), league table, decision making (DM) plane, and linear programming.
Udomsak SAENGOW
doaj +3 more sources
Cost-utility analysis of thrombolytic therapy [PDF]
An analysis of the cost-effectiveness of thrombolytic therapy was performed, based on 3- to 5-year follow-up data, from 533 patients randomized to receive conventional therapy or intracoronary streptokinase. At the 3-year follow-up, mortality was 22% in the former group and 14% after thrombolysis.
M L, Simoons, J, Vos, L L, Martens
openaire +2 more sources
Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
Background Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019. Over six million deaths worldwide have been associated with coronavirus disease 2019.
Metry Andrew +7 more
doaj +1 more source
To systematically review the cost-utility evidence of TNF-a-i treatment for rheumatoid arthritis (RA) and to estimate the pooled incremental net benefit (INBp).
Bhavani Shankara Bagepally (10717496) +1 more
core +1 more source
Economic evaluation of using pesticides to control cutaneous leishmaniasis in Isfahan
Objective: Pesticides have been used as the main part of the national cutaneous leishmaniasis control program for serveral years in Iran. However, the cost-effectiveness of this strategy has not been yet analyzed.
Ehsanallah Jafari +3 more
doaj +1 more source

